Centene CapEx decreased by 6.1% to $200.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 48.1%, from $135.00M to $200.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -4.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $250.00M | $225.00M | $248.00M | $242.00M | $282.00M | $247.00M | $233.00M | $225.00M | $215.00M | $136.00M | $223.00M | $151.00M | $186.00M | $153.00M | $154.00M | $135.00M | $208.00M | $211.00M | $213.00M | $200.00M |
| QoQ Change | — | -10.0% | +10.2% | -2.4% | +16.5% | -12.4% | -5.7% | -3.4% | -4.4% | -36.7% | +64.0% | -32.3% | +23.2% | -17.7% | +0.7% | -12.3% | +54.1% | +1.4% | +0.9% | -6.1% |
| YoY Change | — | — | — | — | +12.8% | +9.8% | -6.0% | -7.0% | -23.8% | -44.9% | -4.3% | -32.9% | -13.5% | +12.5% | -30.9% | -10.6% | +11.8% | +37.9% | +38.3% | +48.1% |